Combined inhibition of Aurora-A and ATR kinases results in regression of MYCN-amplified neuroblastoma
Isabelle Roeschert, Evon Poon, Anton G. Henssen, Heathcliff Dorado García, Marco Gatti, Celeste Giansanti, Yann Jamin, Carsten P. Ade, Peter Gallant, Christina Schülein‐Völk, Petra Beli, Mark W. Richards, Mathias T. Rosenfeldt, Matthias Altmeyer, John Anderson, Angelika Eggert, Matthias Dobbelstein, Richard Bayliss, Louis Chesler, Gabriele Büchel, Martin Eilers
Topics & Concepts
NeuroblastomaAurora kinaseCancer researchAurora inhibitorChromatinKinaseBiologyHistone H3HistoneAurora A kinaseCell biologyCell cycleApoptosisGeneticsDNACell cultureNeuroblastoma Research and TreatmentsUbiquitin and proteasome pathwaysCancer, Hypoxia, and Metabolism